Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines

被引:205
作者
Kawashima, H
Atarashi, K
Hirose, M
Hirose, J
Yamada, S
Sugahara, K
Miyasaka, M
机构
[1] Osaka Univ, Lab Mol & Cellular Recognit, Grad Sch Med, Suita, Osaka 5650871, Japan
[2] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan
关键词
D O I
10.1074/jbc.M200396200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that versican, a large chondroitin/dermatan sulfate (CS/DS) proteoglycan, interacts through its CS/DS chains with adhesion molecules L- and P-selectin and CD44, as well as chemokines. Here, we have characterized these interactions further. Using a metabolic inhibitor of sulfation, sodium chlorate, we show that the interactions of the CS/DS chains of versican with L- and P-selectin and chemokines are sulfation-dependent but the interaction with CD44 is sulfation-independent. Consistently, versican's binding to L- and P-selectin and chemokines is specifically inhibited by oversulfated CS/DS chains containing G1cAbeta1-3GalNAc(4,6-O-disulfate) or IdoAalpha1-3GalNAc(4,6-O-disulfate), but its binding to CD44 is inhibited by all the CS/DS chains, including low-sulfated and unsulfated ones. Affinity and kinetic analyses using surface plasmon resonance revealed that the oversulfated CS/DS chains containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) bind directly to selectins and chemokines with high affinity (K-d 21.1 to 293 nm). In addition, a tetrasaccharide fragment of repeating GlcAbeta1-3GalNAc(4,6-O-disulfate) units directly interacts with L- and P-selectin and chemokines and oversulfated CS/DS chains containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) inhibit chemokine-induced Ca2+ mobilization. Taken together, our results show that oversulfated CS/DS chains containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) are recognized by L- and P-selectin and chemokines, and imply that these chains are important in selectin- and/or chemokine-mediated cellular responses.
引用
收藏
页码:12921 / 12930
页数:10
相关论文
共 40 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[3]   Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin [J].
Bistrup, A ;
Bhakta, S ;
Lee, JK ;
Belov, YY ;
Gunn, MD ;
Zuo, FR ;
Huang, CC ;
Kannagi, R ;
Rosen, SD ;
Hemmerich, S .
JOURNAL OF CELL BIOLOGY, 1999, 145 (04) :899-910
[4]   Distribution of the large aggregating proteoglycan versican in adult human tissues [J].
BodeLesniewska, B ;
DoursZimmermann, MT ;
Odermatt, BF ;
Briner, J ;
Heitz, PU ;
Zimmermann, DR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (04) :303-312
[5]   CD44 binds a chondroitin sulfate proteoglycan, aggrecan [J].
Fujimoto, T ;
Kawashima, H ;
Tanaka, T ;
Hirose, M ;
Toyama-Sorimachi, N ;
Matsuzawa, Y ;
Miyasaka, M .
INTERNATIONAL IMMUNOLOGY, 2001, 13 (03) :359-366
[6]   A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewisx, an L-selectin ligand displayed by CD34 [J].
Hiraoka, N ;
Petryniak, B ;
Nakayama, J ;
Tsuboi, S ;
Suzuki, M ;
Yeh, JC ;
Izawa, D ;
Tanaka, T ;
Miyasaka, M ;
Lowe, JB ;
Fukuda, M .
IMMUNITY, 1999, 11 (01) :79-89
[7]   Versican interacts with chemokines and modulates cellular responses [J].
Hirose, J ;
Kawashima, H ;
Yoshie, O ;
Tashiro, K ;
Miyasaka, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :5228-5234
[8]  
IMAI Y, 1993, NATURE, V361, P555
[9]  
KATZ HR, 1986, J BIOL CHEM, V261, P3393
[10]   Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin [J].
Kawashima, H ;
Li, YF ;
Watanabe, N ;
Hirose, J ;
Hirose, M ;
Miyasaka, M .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (03) :393-405